| | |
Per Share
|
| |
Total
|
| | | | ||||||
Public Offering Price
|
| | | $ | 9.97 | | | | | $ | 219,340,000 | | | | ||
Underwriting Discounts and Commissions(1)
|
| | | $ | 0.5982 | | | | | $ | 13,160,400 | | | | ||
Offering to Iovance Biotherapeutics, Inc. before expenses
|
| | | $ | 9.3718 | | | | | $ | 206,179,600 | | | |
TABLE OF CONTENTS
|
| | | | | |
| | |
Page
|
|||
Prospectus Supplement | | | ||||
| | | | S-ii | ||
| | | | S-iii | ||
Summary | | | | | S-1 | |
| | | | S-6 | ||
| | | | S-9 | ||
| | | | S-10 | ||
| | | | S-14 | ||
| | | | S-21 | ||
| | | | S-21 | ||
| | | | S-21 | ||
| | | | S-22 | ||
| | | | | Page | |
Prospectus | | | | | | |
| | | | 1 | ||
| | | | 2 | ||
| | | | 4 | ||
| | | | 5 | ||
| | | | 6 | ||
| | | | 7 | ||
| | | | 8 | ||
| | | | 9 | ||
| | | | 9 | ||
| | | | 11 | ||
| | | | 14 | ||
| | | | 22 | ||
| | | | 23 | ||
| | | | 24 | ||
| | | | 26 | ||
| | | | 28 | ||
| | | | 28 | ||
| | | | 28 | ||
| | | | 29 |
Underwriter
|
| |
Number of
Shares |
| |||
Jefferies LLC
|
| | | | 22,000,000 | | |
Total
|
| | | | 22,000,000 | | |
|
| | |
PER SHARE
|
| |
TOTAL
|
| ||||||||||||||||||
| | |
WITHOUT
OPTION TO PURCHASE ADDITIONAL SHARES |
| |
WITH
OPTION TO PURCHASE ADDITIONAL SHARES |
| |
WITHOUT
OPTION TO PURCHASE ADDITIONAL SHARES |
| |
WITH
OPTION TO PURCHASE ADDITIONAL SHARES |
| ||||||||||||
Public offering price
|
| | | $ | 9.97 | | | | | $ | 9.97 | | | | | $ | 219,340,000 | | | | | $ | 252,241,000 | | |
Underwriting discounts and commissions paid by us
|
| | | $ | 0.5982 | | | | | $ | 0.5982 | | | | | $ | 13,160,400 | | | | | $ | 15,134,460 | | |
Proceeds to us, before expenses
|
| | | $ | 9.3718 | | | | | $ | 9.3718 | | | | | $ | 206,179,600 | | | | | $ | 237,106,540 | | |
| | |
Page
|
| |||
| | | | 1 | | | |
| | | | 2 | | | |
| | | | 4 | | | |
| | | | 5 | | | |
| | | | 6 | | | |
| | | | 7 | | | |
| | | | 8 | | | |
| | | | 9 | | | |
| | | | 9 | | | |
| | | | 11 | | | |
| | | | 14 | | | |
| | | | 22 | | | |
| | | | 23 | | | |
| | | | 24 | | | |
| | | | 26 | | | |
| | | | 28 | | | |
| | | | 28 | | | |
| | | | 28 | | | |
| | | | 29 | | |
| | |
Year Ended December 31,
|
| |
Six Months
Ended June 30, 2018 |
| ||||||||||||||||||||||||||||||
| | |
2017
|
| |
2016
|
| |
2015
|
| |
2014
|
| |
2013
|
| |||||||||||||||||||||
Ratio of earnings to fixed charges(1)
|
| | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | |